These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 15610939)

  • 1. Platelet serotonin uptake and paroxetine binding among allelic genotypes of the serotonin transporter in alcoholics.
    Javors MA; Seneviratne C; Roache JD; Ait-Daoud N; Bergeson SE; Walss-Bass MC; Akhtar FZ; Johnson BA
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):7-13. PubMed ID: 15610939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can serotonin transporter genotype predict serotonergic function, chronicity, and severity of drinking?
    Johnson BA; Javors MA; Roache JD; Seneviratne C; Bergeson SE; Ait-Daoud N; Dawes MA; Ma JZ
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):209-16. PubMed ID: 17950969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between serotonin transporter gene polymorphisms and platelet serotonin transporter sites among African-American cocaine-dependent individuals and healthy volunteers.
    Patkar AA; Berrettini WH; Mannelli P; Gopalakrishnan R; Hoehe MR; Bilal L; Weinstein S; Vergare MJ
    Psychiatr Genet; 2004 Mar; 14(1):25-32. PubMed ID: 15091312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets.
    Greenberg BD; Tolliver TJ; Huang SJ; Li Q; Bengel D; Murphy DL
    Am J Med Genet; 1999 Feb; 88(1):83-7. PubMed ID: 10050973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin transporter promoter variants in autism: functional effects and relationship to platelet hyperserotonemia.
    Anderson GM; Gutknecht L; Cohen DJ; Brailly-Tabard S; Cohen JH; Ferrari P; Roubertoux PL; Tordjman S
    Mol Psychiatry; 2002; 7(8):831-6. PubMed ID: 12232775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity.
    Heinz A; Jones DW; Mazzanti C; Goldman D; Ragan P; Hommer D; Linnoila M; Weinberger DR
    Biol Psychiatry; 2000 Apr; 47(7):643-9. PubMed ID: 10745057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drinking histories in alcohol-use-disordered youth: preliminary findings on relationships to platelet serotonin transporter expression with genotypes of the serotonin transporter.
    Dawes MA; Roache JD; Javors MA; Bergeson SE; Richard DM; Mathias CW; Ait-Daoud N; Dougherty DM; Johnson BA
    J Stud Alcohol Drugs; 2009 Nov; 70(6):899-907. PubMed ID: 19895766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rat strain differences in peripheral and central serotonin transporter protein expression and function.
    Fernandez F; Sarre S; Launay JM; Aguerre S; Guyonnet-Dupérat V; Moisan MP; Ebinger G; Michotte Y; Mormède P; Chaouloff F
    Eur J Neurosci; 2003 Feb; 17(3):494-506. PubMed ID: 12581167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin transporter gene regulatory region polymorphism (5-HTTLPR), [3H]paroxetine binding in healthy control subjects and alcohol-dependent patients and their relationships to impulsivity.
    Preuss UW; Soyka M; Bahlmann M; Wenzel K; Behrens S; de Jonge S; Krüger M; Bondy B
    Psychiatry Res; 2000 Sep; 96(1):51-61. PubMed ID: 10980326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seasonal variations in the binding of [3H]paroxetine to the platelet serotonin transporter sites in African-American cocaine-dependent patients and healthy volunteers.
    Patkar AA; Berrettini WH; Lundy A; Murray HW; Hill KP; Vergare MJ; Weinstein SP
    Hum Psychopharmacol; 2003 Mar; 18(2):103-11. PubMed ID: 12590403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decrease of serotonin transporters in blood platelets after epileptic seizures.
    Cupello A; Favale E; Audenino D; Scarrone S; Gastaldi S; Albano C
    Neurochem Res; 2005 Apr; 30(4):425-8. PubMed ID: 16076011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin transporter polymorphism and bleeding time during SSRI therapy.
    Hougardy DM; Egberts TC; van der Graaf F; Brenninkmeijer VJ; Derijks LJ
    Br J Clin Pharmacol; 2008 May; 65(5):761-6. PubMed ID: 18279474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between serotonin uptake in human blood platelets with the 44-bp polymorphism and the 17-bp variable number of tandem repeat of the serotonin transporter.
    Kaiser R; Müller-Oerlinghausen B; Filler D; Tremblay PB; Berghöfer A; Roots I; Brockmöller J
    Am J Med Genet; 2002 Apr; 114(3):323-8. PubMed ID: 11920857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between low activity serotonin transporter promoter genotype and early onset alcoholism with habitual impulsive violent behavior.
    Hallikainen T; Saito T; Lachman HM; Volavka J; Pohjalainen T; Ryynänen OP; Kauhanen J; Syvälahti E; Hietala J; Tiihonen J
    Mol Psychiatry; 1999 Jul; 4(4):385-8. PubMed ID: 10483057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant correlation between 14C-5-HT uptake by and 3H-paroxetine binding to platelets from healthy volunteers.
    Maguire K; Tuckwell V; Pereira A; Dean B; Singh B
    Biol Psychiatry; 1993 Sep; 34(6):356-60. PubMed ID: 8218602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin transporter gene polymorphisms and platelet [3H] paroxetine binding in premenstrual dysphoria.
    Melke J; Westberg L; Landén M; Sundblad C; Eriksson O; Baghei F; Rosmond R; Eriksson E; Ekman A
    Psychoneuroendocrinology; 2003 Apr; 28(3):446-58. PubMed ID: 12573307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipramine.
    Whale R; Quested DJ; Laver D; Harrison PJ; Cowen PJ
    Psychopharmacology (Berl); 2000 May; 150(1):120-2. PubMed ID: 10867985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the selective serotonin reuptake inhibitor paroxetine on platelet function is modified by a SLC6A4 serotonin transporter polymorphism.
    Abdelmalik N; Ruhé HG; Barwari K; van den Dool EJ; Meijers JC; Middeldorp S; Büller HR; Schene AH; Kamphuisen PW
    J Thromb Haemost; 2008 Dec; 6(12):2168-74. PubMed ID: 18983505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No association between the serotonin transporter-linked promoter region polymorphism and either schizophrenia or density of the serotonin transporter in human hippocampus.
    Naylor L; Dean B; Pereira A; Mackinnon A; Kouzmenko A; Copolov D
    Mol Med; 1998 Oct; 4(10):671-4. PubMed ID: 9848084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelic variation in the serotonin transporter promoter affects neuromodulatory effects of a selective serotonin transporter reuptake inhibitor (SSRI).
    Eichhammer P; Langguth B; Wiegand R; Kharraz A; Frick U; Hajak G
    Psychopharmacology (Berl); 2003 Mar; 166(3):294-7. PubMed ID: 12563545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.